5-Fluorouracil-carboplatin continuous infusion as salvage chemotherapy in advanced cancer

Tumori

Volumn 87, Issue 6, 2001, Pages 383-387

  Recchia, Francesco ^a   De Filippis, Sandro ^a   Rosselli, Michele ^a   Saggio, Gaetano ^a   Piccinini, Massimo ^a   Rea, Silvio ^a  

^a NONE   (Italy)

Author keywords

5 fluorouracil; Advanced pretreated tumors; Carboplatin; Continuous infusion

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; FLUOROURACIL; DEXAMETHASONE; ERYTHROPOIETIN; SEROTONIN 3 ANTAGONIST;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLON CANCER; CONTINUOUS INFUSION; DRUG RESPONSE; FEMALE; HUMAN; MALE; NAUSEA; NEUTROPENIA; OUTPATIENT CARE; OVARY CANCER; PHASE 2 CLINICAL TRIAL; STOMACH CANCER; SURVIVAL TIME; TOXICITY; VOMITING; ANEMIA; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER SIZE; CHEMOEMBOLIZATION; COLORECTAL CANCER; ILEUS; INFECTION; LEUKOPENIA; LIVER CELL CARCINOMA; LUNG CANCER; MEDIAN SURVIVAL TIME; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROTOXICITY; PROGRESSION FREE SURVIVAL; THROMBOCYTOPENIA; TREATMENT RESPONSE; X-RAY COMPUTED TOMOGRAPHY;

EID: 0035746542     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160108700605     Document Type: Article

References (17)

1. Dose: A critical factor in cancer chemotherapy
2. Timedose relationship for 5-fluorouracil cytotoxicity against human epithelial cancer cells in vitro
3. Pharmacokinetics of 5-fluorouracil in humans
4. Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: An active new regimen
5. Radiotherapy and concurrent continuous infusion of cisplatin with adjuvant surgery in nonresectable stage III lung carcinoma: Short- and long-term results of a phase II study
6. Prolonged continuous infusion of carboplatin and concomitant radiotherapy in advanced head and neck cancer
7. Two-versus 24-hour infusion of cisplatin: Pharmacokinetic considerations
8. The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined on four human small cell lung cancer cell lines by the clonogenic assay
9. Continuous infusion carboplatin on a 21-day schedule: A phase I pharmacokinetic study
10. Kinetics of cisdichlorodiammineplatinum
11. Chemotherapy of the squamous cell lung cancer LC-12 with 5-fluorouracil, cisplatin, carboplatin or iproplatin combinations
12. The stability of carboplatin in ambulatory continuous infusion regimens
13. Nonparametric estimation from incomplete observations
14. Reporting results of cancer treatment
15. Low-dose continuous infusion 5-fluorouracil. Evaluation in advanced breast cancer
16. Continuous 5-fluorouracil infusion in refractory carcinoma of the breast
17. The activity of a single-agent 5-fluorouracil infusion in advanced head and neck cancer